TN: Approval to 2 new medical colleges, informs minister

Published On 2018-07-08 05:13 GMT   |   Update On 2018-07-08 05:13 GMT

Chennai: The government quota MBBS seats have witnessed a rise from 3,328 seats to 3,501 after the Medical Council of India(MCI), gave its approval to two new medical colleges. This increase in seats has led to the number rising in the ongoing counseling for MBBS and BDS admission 2018-2019.


Health Minister, C Vijaya Baskar while handing over the seat allotments to 10 students on the state’s top ten positions made a confirmation of the MCI approval to the daily The New Indian Expresss, “The MCI gave approval for two self-financing medical colleges, Melmaruvathur Adhiparasakthi Institute of Medical Sciences and Research and Dhanalakshmi Srinivasan Medical College recently.”


The minister said, “Over 70 per cent of seats might go to State Board students and 30 per cent to CBSE and other boards.


The selection committee members revealed that the Dhanalakshmi Srinivasan Medical College had surrendered 75 seats while the Adhiparasakthi Institute had surrendered 98 seats.


Speaking about the Christian Medical College (CMC), Vellore, the minister said the State would act in accordance to the court directive. “The CMC is yet to surrender seats as the case is pending in the court,” he added.


Health Secretary, J Radhakrishnan said, “90 ‘native’ students were added to the rank list and, among them, 28 or so will be eligible for medical seat”.


The selection committee officials said these students had studied in other states and also written NEET-UG from other states, but their parents were domiciled in Tamil Nadu. “One student with similar case went to the court praying to consider him as the state student. The court ruled in his favour. Later we found that there are over 80 similar students and included them in the rank list. However, not all students will get medical seats,” said a senior selection committee official to TNIE


Article Source : with inputs

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News